Document is current
Any future updates will be listed below
-
Authors
Sutter, Raoul https://orcid.org/0000-0002-6575-356X
De Marchis, Gian Marco
Semmlack, Saskia
Fuhr, Peter
Rüegg, Stephan
Marsch, Stephan
Ziai, Wendy C.
Kaplan, Peter W.
- License Information
-
More Information
Article History
First Online: 29 November 2016
Compliance with Ethical Standards
:
: No funding was received for this study. This study was performed and designed without the input or support of any pharmaceutical company, or other commercial interest.
: The authors declare that they have no relevant conflicts of interest related to this study. Dr. Raoul Sutter was supported by the Research Fund of the University Hospital Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. He received a Grant from UCB-pharma and holds stocks from Novartis and Roche since 2005. Dr. Gian Marco De Marchis has no conflicts of interest. Dr. Saskia Semmlack has no conflicts of interest. Dr. Stephan Rüegg received unconditional research grants from UCB-pharma. He received honoraria from serving on the scientific advisory boards of Desitin, Eisai, GSK, and UCB-pharma, travel Grants from GSK, Janssen-Cilag, and UCB-pharma, speaker fees from UCB-pharma and from serving as a consultant for Eisai, GlaxoSmithKline, Janssen-Cilag, Pfizer, Novartis, and UCB-pharma. He does not hold any stocks of any pharmaceutical industries or manufacturers of medical devices. The research of Dr. Peter Fuhr is supported by the Swiss National Science Foundation, the Swiss Parkinson’s Disease Society, the Gossweiler Foundation, the Botnar Foundation, the Scientific Society Basel, the Novartis Foundation, Novartis, and Roche. He received honoraria from serving on the advisory boards of UCB-pharma, Abbott, and Roche. Dr. Stephan Marsch reports no disclosures. Dr. Wendy C. Ziai reports grants from The Epilepsy Foundation. Dr. Peter W. Kaplan has provided unsponsored grand rounds, published books on EEG, status epilepticus and epilepsy, and received non-pharmaceutical industry honoraria for book publications, lectures at Grand Rounds, national and international meetings, and expert witness services on qEEG. He has also acted as a consultant to Lundbeck on antiseizure drugs, and has received a Qatar Research Foundation grant for continuous EEG monitoring in status epilepticus.
: The study was approved by the local ethics committees and institutional review boards of both hospitals (‘Ethikkomission Beider Basel’ and ‘Institutional Review Board of the Johns Hopkins Hospital’) and patients’ consent was waived.
